These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26075468)

  • 1. Methylprednisolone-induced Toxic Hepatitis After Intravenous Pulsed Therapy for Multiple Sclerosis Relapses.
    Ferraro D; Mirante VG; Losi L; Villa E; Simone AM; Vitetta F; Federzoni L; Nichelli PF; Sola P
    Neurologist; 2015 Jun; 19(6):153-4. PubMed ID: 26075468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recurrent acute liver toxicity from intravenous methylprednisolone].
    Rivero Fernández M; Riesco JM; Moreira VF; Moreno A; López San Román A; Arranz G; Ruiz Del Arbol L
    Rev Esp Enferm Dig; 2008 Nov; 100(11):720-3. PubMed ID: 19159178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incomplete septal cirrhosis after high-dose methylprednisolone therapy and regression of liver injury.
    Grilli E; Galati V; Petrosillo N; Del Nonno F; Baiocchini A
    Liver Int; 2015 Feb; 35(2):674-6. PubMed ID: 24906135
    [No Abstract]   [Full Text] [Related]  

  • 4. Methylprednisolone-induced liver injury: Case report and literature review.
    Davidov Y; Har-Noy O; Pappo O; Achiron A; Dolev M; Ben-Ari Z
    J Dig Dis; 2016 Jan; 17(1):55-62. PubMed ID: 26676833
    [No Abstract]   [Full Text] [Related]  

  • 5. Short-term safety of pulse steroid therapy in multiple sclerosis relapses.
    Shaygannejad V; Ashtari F; Alinaghian M; Norouzi R; Salari M; Fatehi F
    Clin Neuropharmacol; 2013; 36(1):1-3. PubMed ID: 23334067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylprednisolone-induced acute liver injury in a patient treated for multiple sclerosis relapse.
    Bresteau C; Prevot S; Perlemuter G; Voican C
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29507031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver injury after methylprednisolone pulses: A disputable cause of hepatotoxicity. A case series and literature review.
    Zoubek ME; Pinazo-Bandera J; Ortega-Alonso A; Hernández N; Crespo J; Contreras F; Medina-Cáliz I; Sanabria-Cabrera J; Sanjuan-Jiménez R; González-Jiménez A; García-Cortés M; Lucena MI; Andrade RJ; Robles-Díaz M
    United European Gastroenterol J; 2019 Jul; 7(6):825-837. PubMed ID: 31316787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver injury after methylprednisolone pulse therapy in multiple sclerosis is usually due to idiosyncratic drug-induced toxicity rather than autoimmune hepatitis.
    Kimura H; Takeda A; Kikukawa T; Hasegawa I; Mino T; Uchida-Kobayashi S; Ohsawa M; Itoh Y
    Mult Scler Relat Disord; 2020 Jul; 42():102065. PubMed ID: 32259746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial.
    Le Page E; Veillard D; Laplaud DA; Hamonic S; Wardi R; Lebrun C; Zagnoli F; Wiertlewski S; Deburghgraeve V; Coustans M; Edan G; ;
    Lancet; 2015 Sep; 386(9997):974-81. PubMed ID: 26135706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous Methylprednisolone-Induced Nocturnal Sinus Bradycardia in a Multiple Sclerosis Patient.
    Osuagwu F; Jahnke B
    Prim Care Companion CNS Disord; 2016; 18(2):. PubMed ID: 27486530
    [No Abstract]   [Full Text] [Related]  

  • 11. Methylprednisolone-induced liver injury: a diagnostic challenge.
    Melamud B; Lurie Y; Goldin E; Levi I; Esayag Y
    Isr Med Assoc J; 2014 Mar; 16(3):180-1. PubMed ID: 24761710
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis.
    Zivadinov R; Zorzon M; De Masi R; Nasuelli D; Cazzato G
    J Neurol Sci; 2008 Apr; 267(1-2):28-35. PubMed ID: 17945260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients.
    Nociti V; Biolato M; De Fino C; Bianco A; Losavio FA; Lucchini M; Marrone G; Grieco A; Mirabella M
    Brain Behav; 2018 Jun; 8(6):e00968. PubMed ID: 29729087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic liver injury after high-dose methylprednisolone in people with multiple sclerosis.
    Adamec I; Pavlović I; Pavičić T; Ruška B; Habek M
    Mult Scler Relat Disord; 2018 Oct; 25():43-45. PubMed ID: 30032042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial.
    Ravnborg M; Sørensen PS; Andersson M; Celius EG; Jongen PJ; Elovaara I; Bartholomé E; Constantinescu CS; Beer K; Garde E; Sperling B
    Lancet Neurol; 2010 Jul; 9(7):672-80. PubMed ID: 20542736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-reported adverse effects of high-dose intravenous methylprednisolone treatment: a prospective web-based multi-center study in multiple sclerosis patients with a relapse.
    Jongen PJ; Stavrakaki I; Voet B; Hoogervorst E; van Munster E; Linssen WH; Sinnige LG; Verhagen WI; Visser LH; van der Kruijk R; Verheul F; Boringa J; Heerings M; Gladdines W; Lönnqvist F; Gaillard P
    J Neurol; 2016 Aug; 263(8):1641-51. PubMed ID: 27272956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced liver injury after high-dose methylprednisolone in a patient with multiple sclerosis.
    Oliveira AT; Lopes S; Cipriano MA; Sofia C
    BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26199298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylprednisolone liver toxicity: A new case and a French regional pharmacovigilance survey.
    Dumortier J; Cottin J; Lavie C; Guillaud O; Hervieu V; Chambon-Augoyard C; Scoazec JY; Vukusic S; Vial T
    Clin Res Hepatol Gastroenterol; 2017 Sep; 41(4):497-501. PubMed ID: 28438569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylprednisolone-induced hepatotoxicity in a 16-year-old girl with multiple sclerosis.
    Rotondo E; Graziosi A; Di Stefano V; Mohn AA
    BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of high-dose intravenous methyl-prednisolone treatment on intraocular pressure in multiple sclerosis patients with relapse.
    Acar M; Gedizlioglu M; Koskderelioglu A; Ozturk F; Kilinc S; Talay N
    Eur Neurol; 2012; 68(1):20-2. PubMed ID: 22677889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.